These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9747251)

  • 21. Weighing benefits and risks of drug to treat obesity.
    Sukkari SR
    CMAJ; 1997 Mar; 156(6):768-9. PubMed ID: 9084379
    [No Abstract]   [Full Text] [Related]  

  • 22. [Benfluorex (Mediator®), our vigilance in question].
    Frachon I
    Presse Med; 2011 May; 40(5):459-61. PubMed ID: 21470816
    [No Abstract]   [Full Text] [Related]  

  • 23. Lessons from the Mediator scandal.
    Prescrire Int; 2011 Dec; 20(122):284. PubMed ID: 22216537
    [No Abstract]   [Full Text] [Related]  

  • 24. Frequency of drug-induced valvular heart disease in patients previously exposd to benfluorex: a multicentre prospective study.
    Tribouilloy C; Maréchaux S; Jobic Y; Jeu A; Ederhy S; Donal E; Réant P; Arnalsteen E; Boulanger J; Garban T; Ennezat PV; Andréjak M; Rusinaru D
    Eur Heart J; 2013 Dec; 34(46):3580-7. PubMed ID: 24014218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Appetite suppressant was probably responsible for 1300 deaths, study shows.
    Benkimoun P
    BMJ; 2012 Feb; 344():e996. PubMed ID: 22323511
    [No Abstract]   [Full Text] [Related]  

  • 26. [Mediator, the police of the medication in question].
    Mauduit L
    Soins; 2011 Apr; (754):6. PubMed ID: 21574303
    [No Abstract]   [Full Text] [Related]  

  • 27. European drug regulator is being investigated by fraud agency.
    Kmietowicz Z
    BMJ; 2011 Nov; 343():d7283. PubMed ID: 22077089
    [No Abstract]   [Full Text] [Related]  

  • 28. European legislators tighten rules on drug safety.
    Watson R
    BMJ; 2012 Sep; 345():e6260. PubMed ID: 22991010
    [No Abstract]   [Full Text] [Related]  

  • 29. In search of a 'magic' pill to treat obesity: the rise and fall of 'Fen-Phen'.
    Capriotti T
    Medsurg Nurs; 1998 Feb; 7(1):52-4. PubMed ID: 9544011
    [No Abstract]   [Full Text] [Related]  

  • 30. Primary pulmonary hypertension and long-term use of appetite suppressants.
    Sztuke-Fournier A
    CMAJ; 1997 Jan; 156(1):89-90, 93-4. PubMed ID: 9006574
    [No Abstract]   [Full Text] [Related]  

  • 31. Restrictive organic mitral regurgitation associated with benfluorex therapy.
    Tribouilloy C; Rusinaru D; Henon P; Tribouilloy L; Leleu F; Andréjak M; Sevestre H; Peltier M; Caus T
    Eur J Echocardiogr; 2010 Aug; 11(7):614-21. PubMed ID: 20237052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Fenfluramine and drug dependence].
    Jorgensen F
    Ugeskr Laeger; 1973 Jan; 135(5):236-8. PubMed ID: 4570417
    [No Abstract]   [Full Text] [Related]  

  • 33. Mediator: who's to blame?
    Braillon A
    Lancet; 2011 Jun; 377(9782):2003-4. PubMed ID: 21665032
    [No Abstract]   [Full Text] [Related]  

  • 34. Was the danger of diet pills overstated?
    Harv Heart Lett; 2000 Feb; 10(6):4-5. PubMed ID: 10799141
    [No Abstract]   [Full Text] [Related]  

  • 35. Studies confirm link between fen-phen and heart-valve disease.
    Harv Heart Lett; 1998 Dec; 9(4):4-6. PubMed ID: 9925979
    [No Abstract]   [Full Text] [Related]  

  • 36. How can benfluorex-related heart valve disease be identified by echocardiography?
    Tribouilloy C; Rusinaru D; Andréjak M
    Arch Cardiovasc Dis; 2011 Oct; 104(10):489-92. PubMed ID: 22044700
    [No Abstract]   [Full Text] [Related]  

  • 37. The need for greater involvement of regulatory agencies in assessing adverse drug reactions.
    Sniderman AD
    CMAJ; 2000 Jan; 162(2):209-10. PubMed ID: 10674055
    [No Abstract]   [Full Text] [Related]  

  • 38. Mediator: who's to blame?
    Waller P; Evans S
    Lancet; 2011 Jun; 377(9782):2002-3. PubMed ID: 21665030
    [No Abstract]   [Full Text] [Related]  

  • 39. Anorectic therapy and valvular heart disease: a reappraisal.
    Silvestry FE; St John Sutton M
    Eur Heart J; 1999 Jul; 20(13):917-20. PubMed ID: 10361039
    [No Abstract]   [Full Text] [Related]  

  • 40. Appetite-suppressant drugs and valvular heart disease.
    Shapiro S
    N Engl J Med; 1999 Feb; 340(6):477-8; author reply 478-80. PubMed ID: 9988622
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.